Edition:
India

MacroGenics Inc (MGNX.OQ)

MGNX.OQ on NASDAQ Stock Exchange Global Select Market

23.46USD
18 Sep 2018
Change (% chg)

-- (--)
Prev Close
$23.46
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
107,616
52-wk High
$32.57
52-wk Low
$16.16

Chart for

About

MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology... (more)

Overall

Beta: 2.78
Market Cap(Mil.): $659.43
Shares Outstanding(Mil.): 36.80
Dividend: --
Yield (%): --

Financials

BRIEF-MacroGenics Posts Qtrly Net Loss Per Common Share Of $1.34

* MACROGENICS PROVIDES UPDATE ON CORPORATE PROGRESS AND 1ST QUARTER 2018 FINANCIAL RESULTS

08 May 2018

BRIEF-Macrogenics Inc Prices Of Public Offering

* MACROGENICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

28 Mar 2018

BRIEF-Macrogenics Announces Proposed Public Offering Of Common Stock

* MACROGENICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

27 Mar 2018

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF236.50 -0.15
Roche Holding Ltd. (RO.S) CHF238.60 -1.20
Amgen, Inc. (AMGN.OQ) $203.20 +0.86
Xencor Inc (XNCR.OQ) $44.92 -0.51

Earnings vs. Estimates